No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.
Background: The study aimed to investigate the pharmacokinetics of intravenous ciprofloxacin and the adequacy of 400 mg every 12 hours in critically ill Intensive Care Unit (ICU) patients on ...
Patients with acute renal failure should be treated with at least 35 ml/kg/h of hemofiltration, hemodiafiltration, or daily hemodialysis, until or unless ongoing multicenter clinical trials indicate ...
Our results suggest that a dose rate of 400 mg every 12 hours, will achieve the recommended PK-PD goals in most patients on CVVHDF. Twice daily dosing of ciprofloxacin maximised peak concentrations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results